Financhill
Buy
68

DHR Quote, Financials, Valuation and Earnings

Last price:
$231.34
Seasonality move :
9.61%
Day range:
$229.79 - $231.73
52-week range:
$171.00 - $258.23
Dividend yield:
0.53%
P/E ratio:
47.64x
P/S ratio:
6.87x
P/B ratio:
3.20x
Volume:
785.8K
Avg. volume:
3.8M
1-year change:
0.31%
Market cap:
$163.5B
Revenue:
$23.9B
EPS (TTM):
$4.86

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DHR
Danaher Corp.
$6B $1.72 3.79% 43.39% $258.09
CTSO
CytoSorbents Corp.
$10M -$0.07 51.05% -41.38% $4.92
DCTH
Delcath Systems, Inc.
$25.3M -$0.09 32.37% -69.37% $22.31
DGX
Quest Diagnostics, Inc.
$2.7B $2.50 5.05% 21.08% $198.06
LH
Labcorp Holdings, Inc.
$3.6B $4.14 6.94% 131.26% $299.71
STRR
Star Operating Cos., Inc.
$16.8M -$0.76 50.04% -65.48% $12.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DHR
Danaher Corp.
$231.47 $258.09 $163.5B 47.64x $0.32 0.53% 6.87x
CTSO
CytoSorbents Corp.
$0.69 $4.92 $43.3M -- $0.00 0% 1.23x
DCTH
Delcath Systems, Inc.
$10.32 $22.31 $364.4M 1,186.21x $0.00 0% 4.92x
DGX
Quest Diagnostics, Inc.
$175.92 $198.06 $19.6B 20.64x $0.80 1.79% 1.83x
LH
Labcorp Holdings, Inc.
$253.15 $299.71 $21B 24.86x $0.72 1.14% 1.55x
STRR
Star Operating Cos., Inc.
$10.90 $12.00 $37.5M 0.75x $0.00 0% 0.52x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DHR
Danaher Corp.
26.23% 0.261 12.96% 0.85x
CTSO
CytoSorbents Corp.
75.25% 1.075 46.74% 1.49x
DCTH
Delcath Systems, Inc.
0.83% 1.825 0.25% 12.82x
DGX
Quest Diagnostics, Inc.
46.79% 0.203 30.05% 0.90x
LH
Labcorp Holdings, Inc.
42.88% 0.863 27.39% 1.10x
STRR
Star Operating Cos., Inc.
26.85% 8.871 70.75% 0.76x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DHR
Danaher Corp.
$3.6B $1.3B 5.07% 6.87% 20.73% $1.4B
CTSO
CytoSorbents Corp.
$6.7M -$2.7M -27.15% -89.32% -28.07% -$2.5M
DCTH
Delcath Systems, Inc.
$17.9M -$388K 1.56% 1.59% -1.89% $4.3M
DGX
Quest Diagnostics, Inc.
$911M $420M 7.41% 14.33% 14.92% $419M
LH
Labcorp Holdings, Inc.
$955.6M $403.2M 5.61% 10.25% 11.32% $280.5M
STRR
Star Operating Cos., Inc.
$5.6M -$866K -2.74% -3.67% -3.65% -$2.4M

Danaher Corp. vs. Competitors

  • Which has Higher Returns DHR or CTSO?

    CytoSorbents Corp. has a net margin of 15% compared to Danaher Corp.'s net margin of -33.42%. Danaher Corp.'s return on equity of 6.87% beat CytoSorbents Corp.'s return on equity of -89.32%.

    Company Gross Margin Earnings Per Share Invested Capital
    DHR
    Danaher Corp.
    59.87% $1.27 $69.2B
    CTSO
    CytoSorbents Corp.
    70.28% -$0.05 $36.4M
  • What do Analysts Say About DHR or CTSO?

    Danaher Corp. has a consensus price target of $258.09, signalling upside risk potential of 11.5%. On the other hand CytoSorbents Corp. has an analysts' consensus of $4.92 which suggests that it could grow by 613.18%. Given that CytoSorbents Corp. has higher upside potential than Danaher Corp., analysts believe CytoSorbents Corp. is more attractive than Danaher Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    DHR
    Danaher Corp.
    18 3 0
    CTSO
    CytoSorbents Corp.
    1 1 0
  • Is DHR or CTSO More Risky?

    Danaher Corp. has a beta of 0.892, which suggesting that the stock is 10.801% less volatile than S&P 500. In comparison CytoSorbents Corp. has a beta of 1.285, suggesting its more volatile than the S&P 500 by 28.454%.

  • Which is a Better Dividend Stock DHR or CTSO?

    Danaher Corp. has a quarterly dividend of $0.32 per share corresponding to a yield of 0.53%. CytoSorbents Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher Corp. pays 20.42% of its earnings as a dividend. CytoSorbents Corp. pays out -- of its earnings as a dividend. Danaher Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DHR or CTSO?

    Danaher Corp. quarterly revenues are $6.1B, which are larger than CytoSorbents Corp. quarterly revenues of $9.5M. Danaher Corp.'s net income of $908M is higher than CytoSorbents Corp.'s net income of -$3.2M. Notably, Danaher Corp.'s price-to-earnings ratio is 47.64x while CytoSorbents Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher Corp. is 6.87x versus 1.23x for CytoSorbents Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DHR
    Danaher Corp.
    6.87x 47.64x $6.1B $908M
    CTSO
    CytoSorbents Corp.
    1.23x -- $9.5M -$3.2M
  • Which has Higher Returns DHR or DCTH?

    Delcath Systems, Inc. has a net margin of 15% compared to Danaher Corp.'s net margin of 4.04%. Danaher Corp.'s return on equity of 6.87% beat Delcath Systems, Inc.'s return on equity of 1.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    DHR
    Danaher Corp.
    59.87% $1.27 $69.2B
    DCTH
    Delcath Systems, Inc.
    87.24% $0.02 $115.8M
  • What do Analysts Say About DHR or DCTH?

    Danaher Corp. has a consensus price target of $258.09, signalling upside risk potential of 11.5%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 116.13%. Given that Delcath Systems, Inc. has higher upside potential than Danaher Corp., analysts believe Delcath Systems, Inc. is more attractive than Danaher Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    DHR
    Danaher Corp.
    18 3 0
    DCTH
    Delcath Systems, Inc.
    5 0 0
  • Is DHR or DCTH More Risky?

    Danaher Corp. has a beta of 0.892, which suggesting that the stock is 10.801% less volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.

  • Which is a Better Dividend Stock DHR or DCTH?

    Danaher Corp. has a quarterly dividend of $0.32 per share corresponding to a yield of 0.53%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher Corp. pays 20.42% of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend. Danaher Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DHR or DCTH?

    Danaher Corp. quarterly revenues are $6.1B, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. Danaher Corp.'s net income of $908M is higher than Delcath Systems, Inc.'s net income of $830K. Notably, Danaher Corp.'s price-to-earnings ratio is 47.64x while Delcath Systems, Inc.'s PE ratio is 1,186.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher Corp. is 6.87x versus 4.92x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DHR
    Danaher Corp.
    6.87x 47.64x $6.1B $908M
    DCTH
    Delcath Systems, Inc.
    4.92x 1,186.21x $20.6M $830K
  • Which has Higher Returns DHR or DGX?

    Quest Diagnostics, Inc. has a net margin of 15% compared to Danaher Corp.'s net margin of 9.13%. Danaher Corp.'s return on equity of 6.87% beat Quest Diagnostics, Inc.'s return on equity of 14.33%.

    Company Gross Margin Earnings Per Share Invested Capital
    DHR
    Danaher Corp.
    59.87% $1.27 $69.2B
    DGX
    Quest Diagnostics, Inc.
    32.35% $2.15 $13.8B
  • What do Analysts Say About DHR or DGX?

    Danaher Corp. has a consensus price target of $258.09, signalling upside risk potential of 11.5%. On the other hand Quest Diagnostics, Inc. has an analysts' consensus of $198.06 which suggests that it could grow by 12.59%. Given that Quest Diagnostics, Inc. has higher upside potential than Danaher Corp., analysts believe Quest Diagnostics, Inc. is more attractive than Danaher Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    DHR
    Danaher Corp.
    18 3 0
    DGX
    Quest Diagnostics, Inc.
    7 10 0
  • Is DHR or DGX More Risky?

    Danaher Corp. has a beta of 0.892, which suggesting that the stock is 10.801% less volatile than S&P 500. In comparison Quest Diagnostics, Inc. has a beta of 0.618, suggesting its less volatile than the S&P 500 by 38.214%.

  • Which is a Better Dividend Stock DHR or DGX?

    Danaher Corp. has a quarterly dividend of $0.32 per share corresponding to a yield of 0.53%. Quest Diagnostics, Inc. offers a yield of 1.79% to investors and pays a quarterly dividend of $0.80 per share. Danaher Corp. pays 20.42% of its earnings as a dividend. Quest Diagnostics, Inc. pays out 39.15% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DHR or DGX?

    Danaher Corp. quarterly revenues are $6.1B, which are larger than Quest Diagnostics, Inc. quarterly revenues of $2.8B. Danaher Corp.'s net income of $908M is higher than Quest Diagnostics, Inc.'s net income of $257M. Notably, Danaher Corp.'s price-to-earnings ratio is 47.64x while Quest Diagnostics, Inc.'s PE ratio is 20.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher Corp. is 6.87x versus 1.83x for Quest Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DHR
    Danaher Corp.
    6.87x 47.64x $6.1B $908M
    DGX
    Quest Diagnostics, Inc.
    1.83x 20.64x $2.8B $257M
  • Which has Higher Returns DHR or LH?

    Labcorp Holdings, Inc. has a net margin of 15% compared to Danaher Corp.'s net margin of 7.34%. Danaher Corp.'s return on equity of 6.87% beat Labcorp Holdings, Inc.'s return on equity of 10.25%.

    Company Gross Margin Earnings Per Share Invested Capital
    DHR
    Danaher Corp.
    59.87% $1.27 $69.2B
    LH
    Labcorp Holdings, Inc.
    26.82% $3.12 $15.2B
  • What do Analysts Say About DHR or LH?

    Danaher Corp. has a consensus price target of $258.09, signalling upside risk potential of 11.5%. On the other hand Labcorp Holdings, Inc. has an analysts' consensus of $299.71 which suggests that it could grow by 18.39%. Given that Labcorp Holdings, Inc. has higher upside potential than Danaher Corp., analysts believe Labcorp Holdings, Inc. is more attractive than Danaher Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    DHR
    Danaher Corp.
    18 3 0
    LH
    Labcorp Holdings, Inc.
    12 5 0
  • Is DHR or LH More Risky?

    Danaher Corp. has a beta of 0.892, which suggesting that the stock is 10.801% less volatile than S&P 500. In comparison Labcorp Holdings, Inc. has a beta of 0.989, suggesting its less volatile than the S&P 500 by 1.121%.

  • Which is a Better Dividend Stock DHR or LH?

    Danaher Corp. has a quarterly dividend of $0.32 per share corresponding to a yield of 0.53%. Labcorp Holdings, Inc. offers a yield of 1.14% to investors and pays a quarterly dividend of $0.72 per share. Danaher Corp. pays 20.42% of its earnings as a dividend. Labcorp Holdings, Inc. pays out 32.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DHR or LH?

    Danaher Corp. quarterly revenues are $6.1B, which are larger than Labcorp Holdings, Inc. quarterly revenues of $3.6B. Danaher Corp.'s net income of $908M is higher than Labcorp Holdings, Inc.'s net income of $261.5M. Notably, Danaher Corp.'s price-to-earnings ratio is 47.64x while Labcorp Holdings, Inc.'s PE ratio is 24.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher Corp. is 6.87x versus 1.55x for Labcorp Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DHR
    Danaher Corp.
    6.87x 47.64x $6.1B $908M
    LH
    Labcorp Holdings, Inc.
    1.55x 24.86x $3.6B $261.5M
  • Which has Higher Returns DHR or STRR?

    Star Operating Cos., Inc. has a net margin of 15% compared to Danaher Corp.'s net margin of 14.56%. Danaher Corp.'s return on equity of 6.87% beat Star Operating Cos., Inc.'s return on equity of -3.67%.

    Company Gross Margin Earnings Per Share Invested Capital
    DHR
    Danaher Corp.
    59.87% $1.27 $69.2B
    STRR
    Star Operating Cos., Inc.
    23.43% $0.86 $85.6M
  • What do Analysts Say About DHR or STRR?

    Danaher Corp. has a consensus price target of $258.09, signalling upside risk potential of 11.5%. On the other hand Star Operating Cos., Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 10.09%. Given that Danaher Corp. has higher upside potential than Star Operating Cos., Inc., analysts believe Danaher Corp. is more attractive than Star Operating Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    DHR
    Danaher Corp.
    18 3 0
    STRR
    Star Operating Cos., Inc.
    1 1 0
  • Is DHR or STRR More Risky?

    Danaher Corp. has a beta of 0.892, which suggesting that the stock is 10.801% less volatile than S&P 500. In comparison Star Operating Cos., Inc. has a beta of 2.714, suggesting its more volatile than the S&P 500 by 171.399%.

  • Which is a Better Dividend Stock DHR or STRR?

    Danaher Corp. has a quarterly dividend of $0.32 per share corresponding to a yield of 0.53%. Star Operating Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher Corp. pays 20.42% of its earnings as a dividend. Star Operating Cos., Inc. pays out 19.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios DHR or STRR?

    Danaher Corp. quarterly revenues are $6.1B, which are larger than Star Operating Cos., Inc. quarterly revenues of $23.7M. Danaher Corp.'s net income of $908M is higher than Star Operating Cos., Inc.'s net income of $3.5M. Notably, Danaher Corp.'s price-to-earnings ratio is 47.64x while Star Operating Cos., Inc.'s PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher Corp. is 6.87x versus 0.52x for Star Operating Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DHR
    Danaher Corp.
    6.87x 47.64x $6.1B $908M
    STRR
    Star Operating Cos., Inc.
    0.52x 0.75x $23.7M $3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock